Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
CNS inflammation other than multiple sclerosis: How likely is diagnosis?
Human vaccines & immunotherapeutics: news.
Interferon beta-1a for multiple sclerosis: old drug, new clothes.
You're the Flight Surgeon.
Multiple sclerosis: Neuroimaging provides insights into cognitive dysfunction in MS.
Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.
Cortical and leptomeningeal involvement in three cases of neuromyelitis optica.
Acute Disseminated Encephalomyelitis (ADEM)-A Rare Complication of Falciparum Malaria.
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis.
Insulator Protein Helps Organize the Gaps in the Axon's Insulation.
Multiple sclerosis severity and concern about falling: Physical, cognitive and psychological mediating factors.
Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders.
Biogen Reports Top-Line Results from Phase 3 Study Evaluating Natalizumab in Secondary Progressive MS
Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database.
New methods for analysis of oxysterols and related compounds by LC-MS.
Efficacy of A Telephone-Delivered Self-Management Intervention For Persons With Multiple Sclerosis: a Randomized Controlled Trial With a One-Year Follow-Up.
Visibility of lipid resonances in HR-MAS spectra of brain biopsies subject to spinning rate variation.
The temporal dynamics of visual processing in multiple sclerosis.
Multiple sclerosis in the Southern and Northern hemispheres: the month of birth at different latitudes has the same influence on the prevalence and progression of the disease in the Northern and Southern hemispheres?
Treatment of cognitive impairment in multiple sclerosis: position paper.
Cladribine in multiple sclerosis: pitfalls in a new treatment landscape.
Historical changes of seasonal differences in the frequency of multiple sclerosis clinical attacks: a multicenter study.
The impact of self-transcendence on physical health status promotion in multiple sclerosis patients attending peer support groups.
Curcumin ameliorates rat experimental autoimmune neuritis.
[Case of neuromyelitis optica].
Pages
« first
‹ previous
…
359
360
361
362
363
364
365
366
367
…
next ›
last »